Month: October 2021

  • Oppedahl Patent Law Firm LLC will be offering a webinar entitled "Don't End Up Like the Owner of That CRISPR Patent" on October 25, 2021 from 3:00 to 4:30 pm (Mountain Time).  Carl Oppedahl of Oppedahl Patent Law Firm LLC will discuss a January 2020 decision by the Board of Appeal at the European Patent…

  • IPWatchdog and Triangle IP and will be offering a webinar entitled "Patent Purgatory: How the USPTO Puts Patent Applications on Hold, and How One Inventor Is Fighting Back" on October 26, 2021 at 12:00 pm (ET).  Independent inventor Gilbert Hyatt; Andrew Grossman of BakerHostetler; Paul Kamenar, Senior Fellow of the Administrative Conference of the United…

  • IPWatchdog and Questel and will be offering a webinar entitled "How Corporations Can Manage IP Budgets to Reduce Unnecessary Spend" on October 27, 2021 at 11:00 am (ET).  John D'Antico and Eric Moran of Questel and Gene Quinn of IPWatchdog, Inc. will discuss how savvy service providers, and IP leaders, are using AI as a…

  • The Federal Circuit Bar Association (FCBA) will be offering a remote program entitled "Breaking Global Developments (AI, UPC)" on October 28, 2021 from 11:00 am to 12:00 pm (ET).  Greg Gramenapaulos of Finnegan, Henderson, Farabow, Garrett & Dunner LLP will moderate a panel consisting of Clemens Heusch of Nokia Corporation, Tim Powell of Powell Gilbert…

  • IPWatchdog and Innovation Alliance and will be offering a webinar entitled "The Good, the Bad, and the Ugly: Outlook for the U.S. Patent System" on October 28, 2021 at 1:00 pm (ET).  Kathleen M. O'Malley, Circuit Judge of the United States Court of Appeals for the Federal Circuit; Eddie Lazarus, Chief Legal Officer, Sonos; Jonathan…

  • The UIC Law Center for Intellectual Property, Information & Technology Law will host its 65th Annual Intellectual Property Conference on November 4-5, 2021 as a virtual conference.  The conference will run from 7:30 am to 4:15 pm CDT on both days. Featured speakers include current Federal Circuit Judge Kathleen O'Malley, former Federal Circuit Chief Judge…

  • By Kevin E. Noonan — On October 15th, the Food and Drug Administration approved its second interchangeable biosimilar drug.  That drug is Cyltezo (adalimumab-adbm), produced by Boehringer Ingelheim, which obtained biosimilar approval on August 25, 2017.  In this recent approval, the FDA determined that Cyltezo is interchangeable with AbbVie's Humira (adalimumab), its reference product.  Cyltezo…

  • By Kevin E. Noonan — On May 20th, Junior Party the University of California, Berkeley; the University of Vienna; and Emmanuelle Charpentier (collectively, "CVC") filed their Substantive Preliminary Motion No. 2 in Interference No. 106,127 (which names ToolGen as Senior Party), asking the Patent Trial and Appeal Board to deny ToolGen benefit of priority to…

  • By Kevin E. Noonan — On May 28th, Junior Party the Broad Institute, Harvard University and MIT (collectively, "Broad") filed its Preliminary Motion No. 2 in CRISPR Interference No. 106,126 (where ToolGen is the Senior Party), contingent on the Board's grant of Broad's Substantive Preliminary Motion No. 1 to substitute (in part) a new Count No. 2…

  • Schwegman Lundberg & Woessner will be offering a webinar entitled "How Automation and AI are Changing Professional Opportunities in the IP Profession" on October 19, 2021 at 12:00 pm (CT).  Russ Slifer, Ellen Franco, and Adam Reece of Black Hills IP; Manjeet Rege, Director of the Center for Applied Artificial Intelligence, University of St. Thomas;…